What is a Continuation-In-Part (CIP) application?
A Continuation-In-Part (CIP) application is a type of patent application that contains a portion or all of the disclosure of an earlier application and adds matter not disclosed in the earlier parent application. The new matter in a CIP application can be claimed, but it may affect the effective filing date of certain claims. According…
Read MoreWhat is the impact of prior art on CIP applications?
The impact of prior art on Continuation-In-Part (CIP) applications can be significant, especially for claims that are only supported by the CIP disclosure and not the parent application. According to MPEP 2133.01: “Any prior art disclosing the invention or an obvious variant thereof having a critical reference date more than 1 year prior to the…
Read MoreCan a parent application be used as prior art against a CIP application?
Yes, a parent application can be used as prior art against claims in a Continuation-In-Part (CIP) application that are not fully supported by the parent application. This situation is addressed in MPEP 2133.01, which cites a relevant case: “See, e.g., Santarus, Inc. v. Par Pharmaceutical, Inc., 694 F.3d 1344, 104 USPQ2d 1641 (Fed. Cir. 2012)(patent…
Read MoreWhat is the significance of the one-year bar in relation to CIP applications?
The one-year bar is particularly significant for Continuation-In-Part (CIP) applications, especially for claims that are only supported by the CIP disclosure. According to MPEP 2133.01: “Any prior art disclosing the invention or an obvious variant thereof having a critical reference date more than 1 year prior to the filing date of the child will bar…
Read MoreWhat is the significance of “intervening references” in CIP application rejections?
“Intervening references” are particularly important in the examination of Continuation-In-Part (CIP) applications. The MPEP 2133.01 states: “[T]he examiner must consider if any reference that would qualify as prior art under pre-AIA 35 U.S.C. 102(e) as of the filing date of the CIP application would also qualify as prior art under pre-AIA 35 U.S.C. 102(b) as…
Read MoreHow does the “effective filing date” affect CIP applications in patent examination?
The “effective filing date” plays a crucial role in the examination of Continuation-In-Part (CIP) applications. According to MPEP 2133.01: “The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis.” This means that: Each claim in a CIP application is evaluated separately to determine its effective filing…
Read MoreHow is the effective filing date determined for claims in a CIP application?
The effective filing date for claims in a Continuation-In-Part (CIP) application is determined on a claim-by-claim basis, not an application-by-application basis. This means that different claims within the same CIP application may have different effective filing dates. According to MPEP 2133.01: “Any claim that only contains subject matter that is fully supported in compliance with…
Read MoreHow do examiners determine which claims in a CIP application are entitled to the parent application’s filing date?
Examiners must carefully analyze each claim in a Continuation-In-Part (CIP) application to determine which are entitled to the parent application’s filing date. The MPEP 2133.01 provides guidance: “If an application is a continuation-in-part of an earlier U.S. application or international application, any claims in the new application not supported by the specification and claims of…
Read MoreHow does the AIA (America Invents Act) affect the treatment of CIP applications?
The America Invents Act (AIA) significantly changed the treatment of Continuation-In-Part (CIP) applications for patents filed on or after March 16, 2013. The MPEP 2133.01 notes: “[Editor Note: This MPEP section is not applicable to applications subject to examination under the first inventor to file (FITF) provisions of the AIA as set forth in 35…
Read More